EPD Other Income/Expenses (Net)

Enterprise Products Partners L.P. Common Stock · Other Income/Expenses (Net)

EPD logo

EPD Other Income/Expenses (Net)

Latest reported-$1.20B
EPD TTM Other Income/Expenses (Net) (-$388.20M → -$1.20B)
High-resolution chart · PNG

EPD other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Enterprise Products Partners L.P. Common Stock Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-1,199,000,000
-1,160,000,000
-1,190,000,000
-1,232,000,000
-1,219,000,000
-1,316,000,000
-1,303,000,000
-1,295,000,000
-1,289,000,000
-1,244,000,000
-1,228,000,000
-1,196,000,000
-1,174,000,000
-1,196,000,000
-1,210,000,000
-1,251,000,000
-1,264,000,000
-1,272,000,000
-1,278,000,000
-1,280,000,000
-1,282,600,000
-1,284,000,000
-1,273,700,000
-1,230,100,000
-1,326,500,000
-1,324,200,000
-1,346,000,000
-1,371,000,000
-1,254,700,000
-1,221,400,000
-1,109,800,000
-1,076,900,000
-1,031,700,000
-1,014,900,000
-1,047,599,999
-1,014,299,999
-1,018,899,999
-1,021,899,999
-1,004,300,000
-1,009,000,000
-998,100,000
-982,700,000
-984,300,000
-975,700,000
-960,300,000
-936,500,000
-919,100,000
-878,300,000
-855,200,000
-817,400,000
-749,900,000
-734,100,000
-746,700,000
-730,100,000
-704,200,000
-703,800,000
-673,500,000
-677,000,000
-732,500,000
-792,500,000
-780,900,000
-772,200,000
-738,800,000
-766,400,000
-716,000,000
-705,500,000
-706,900,000
-540,776,000
-514,292,000
-451,662,000
-391,362,000
-377,722,000
-359,575,000
-335,053,000
-305,483,000
-275,609,000
-252,897,000
-235,289,000
-229,967,000
-227,744,000
-226,231,000
-228,792,000
-225,178,000
-224,733,000
-197,877,000
-174,148,000
-157,284,000
-131,469,000
-131,284,000
-130,960,000
-136,728,000
-134,260,000
-133,576,000
-93,738,000
-42,107,000
-3,648,000
34,177,000
34,586,000
25,705,000
18,465,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.